Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 2 lineages in European COVID-19 cohorts
Contributing partner:
UANTWERPEN, Belgium
Scientific article available at:
“Euro Surveill”
Lessons learned from the COVID-19 pandemic: identifying hesitant groups and exploring reasons for vaccination hesitancy, from adolescence to late adulthood
Contributing partner:
LIH, Luxembourg
Scientific article available at:
“Frontiers”
Temporal Dynamics and (Para)Clinical Factors Associated With (Long) Viral RNA Shedding in COVID-19 Nonhospitalized Individuals – The COVID-HOME Study
Contributing partner:
UMCG, the Netherlands
Scientific article available at:
“J Med Virol”
Learning from post-COVID-19 condition for epidemic preparedness: a variable catalogue for future post-acute infection syndromes
Contributing partner:
UNIVR, Italy
Scientific article available at:
“Clin Microbiol Infect”
Modeling the effectiveness of antiviral treatment strategies to prevent within household transmission of acute respiratory viruses
Contributing partner:
INSERM, France
Scientific article available at:
“Plos”
Socio-demographic and clinical predictors of post-acute, mid-and long-term psychological sequelae of COVID-19: a two-year cross-sectional investigation on 1317 patients at the University Hospital of Verona
Contributing partner:
UNIVR, Italy
Scientific article available at:
“Arch Public Health”
Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections
Contributing partner:
LMU, Munich
Scientific article available at:
“viruses”
The gut microbiota as an early predictor of COVID-19 severity
Contributing partner:
CINECA, Italy
Scientific article available at:
“mSphere”
Chemosensory assessment and impact on quality of life in neurosensorial cluster of the post COVID 19 syndrome
Contributing partner:
UNIVR, Italy
Scientific article available at:
“Scientific Reports”
Privacy-Preserving Workflow for the Cross-Border Federated Analysis of Clinical Data
Contributing partner:
Life and Medical Sciences Institute, University of Bonn, Germany
Scientific article available at:
“Stud Health Technol Inform”
Systemic oxidative stress associates with the development of post-COVID-19 syndrome in non-hospitalized individuals
Contributing partner:
UMCG, Netherlands
Scientific article available at:
“PDS”
Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV
Contributing partner:
CINECA, Italy
Scientific article available at:
“PDS”
Use of Azithromycin Attributable to Acute SARS-CoV-2 Infection
Contributing partner:
RER-ASSR
Scientific article available at:
“PDS”
Temporal changes in the risk of six-month post-COVID symptoms: a national population-based cohort study
Contributing partner:
INSERM, France
Scientific article available at:
“American Journal of Epidemiology”
Creation of Standardized Common Data Elements for Diagnostic Tests in Infectious Disease Studies: Semantic and Syntactic Mapping
Contributing partner:
Charité, Berlin; University Hospital of Cologne
Scientific article available at:
“Journal of Medical Internet Research”
An innovative technological infrastructure for managing SARS-CoV-2 data across different cohorts in compliance with General Data Protection Regulation
Contributing partner:
CINECA, Italy
Scientific article available at:
“Digital Health”
A Scalable Pseudonymization Tool for Rapid Deployment in Large Biomedical Research Networks: Development and Evaluation Study
Contributing partner:
CINECA, Italy
Scientific article available at:
“JMIR Med Inform”
A Dried Blood Spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system
Contributing partner:
Ludwig-Maximilian – Universität München (LMU)
Scientific article available at:
“PDS”
Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)
Contributing partner:
Luxembourg Institute of Health (LIH), Luxembourg
Scientific article available at:
“BMC Infectious Diseases”
Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge-ORCHESTRA project
Contributing partner:
UNIVR, Italy
Scientific article available at:
“Springer”
Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge-ORCHESTRA project
Contributing partner:
UNIVR, Italy
Scientific article available at:
“Infection”
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study
Contributing partner:
University of Verona
Scientific article available at:
“Plos One”
Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5–11 years old children with prior COVID-19
Contributing partner:
Fondazione Penta ONLUS, Padova
Scientific article available at:
“Vaccine”
Mucosal response of inactivated and recombinant COVID-19 vaccines in Congolese individuals
Contributing partner:
Fondation Congolaise pour la Recherche Médicale (FCRM)
Scientific article available at:
“Immunity, Inflammation and Disease”
Chest Computed Tomography Characteristics of Critically Ill COVID-19 Patients with Auto-antibodies Against Type I Interferons
Contributing partner:
INSERM, Paris
Scientific article available at:
“Journal of Clinical Immunology”
From intentions to practices: what drove people to get the COVID-19 vaccine? Findings from the French longitudinal socioepidemiological cohort survey
Contributing partner:
INSERM, Paris
Scientific article available at:
“BMJ Open”
The impact of SARS-CoV-2 on healthcare workers of a large University Hospital in the Veneto Region: risk of infection and clinical presentation in relation to different pandemic phases and some relevant determinants
Contributing partner:
University of Padova
Scientific article available at:
“Frontiers in Public Health”
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients
Contributing partner:
INSERM, Paris
Scientific article available at:
“Journal of Medical Virology”
ISO/TS 21564:2019- based Evaluation of a Semantic Map between Variables in the ISARIC Freestanding Follow Up Survey and ORCHESTRA Studies
Contributing partner:
Berlin Institute of Health (BIH/Charité)
Scientific article available at:
“Journal of Medical Systems”
ISO/TS 21564:2019- based Evaluation of a Semantic Map between Variables in the ISARIC Freestanding Follow Up Survey and ORCHESTRA Studies
Contributing partner:
Berlin Institute of Health, Charité, Berlin
Scientific article available at:
“Journal of Medical Systems”
Development, validation, and accuracy of ORCHESTRA emotional exhaustion screening questionnaire among healthcare workers during COVID-19 Pandemic
Contributing partner:
The University of Oviedo (UNIOVI)
Scientific article available at:
“British Journal of Health Psychology”
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio
Contributing partner:
Italian National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome
Scientific article available at:
“Vaccines”
A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing Humoral Immunity—ORCHESTRA Project
Contributing partner:
University of Trieste
Scientific article available at:
“Vaccines”
Immunological biomarkers of COVID-19 : response to vaccination and monoclonal antibody treatments in immunocompromised patients
Contributing partner:
University of Antwerpen
Scientific article available at:
“Repository UAntwerpen”
A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of Coronavirus Disease 2019 (COVID-19) Prognostic Scores
Contributing partner:
University Hospital Cologne (UHC)
Scientific article available at:
“Clinical Infectious Diseases”
Graphical Abstract available here
Differences by immigration status on Covid-19 acute outcomes in the Emilia-Romagna ORCHESTRA cohort
Contributing partner:
Regione Emilia Romagna- Agenzia Sanitaria e Sociale (RER-ASSR)
Scientific article available at:
“European Journal of Public Health”
International Clinical Research Data Ecosystem: From Data Standardization to Federated Analysis
Contributing partner:
CINECA Consorzio Interuniversitario
Scientific article available at:
“Studies in Health Technology and Informatics”
Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern
Contributing partner:
Luxembourg Institute of Health (LIH)
Scientific article available at:
“International Journal of Molecular Sciences”
SARS-CoV-2 Infections, Re-Infections and Clinical Characteristics: A Two-Year Retrospective Study in a Large University Hospital Cohort of Vaccinated Healthcare Workers
Contributing partner:
University of Bologna
Scientific article available at:
“Journal of Clinical Medicine”
The incidence and risk factors of selected drug prescriptions and outpatient care after SARS-CoV-2 infection in low-risk subjects: a multicenter population-based cohort study
Contributing partner:
Regional Agency for Health and Social Care of Emilia-Romagna Region (RER-ASSR)
Scientific article available at:
“Frontiers in Public Health”
Determinants of Anti-S Immune Response at 12 Months after SARS-CoV-2 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“Vaccines”
Enabling Open Science in Medicine Through Data Sharing: An Overview and Assessment of Common Approaches from the European Perspective
Contributing partner:
Berlin Institute of Health (BIH/Charité)
Scientific article available at:
“Journal of Open Access to Law”
Comparative study showed that children faced a 78% higher risk of new-onset conditions after they had COVID-19
Contributing partner:
Penta–Child Health Research, Padua, Italy
Scientific article available at:
“Acta Paediatrica”
Development, Validation, and Accuracy of ORCHESTRA Emotional Exhaustion Questionnaire
Contributing partner:
The University of Oviedo (UNIOVI)
Scientific article available at:
“Gaceta Sanitaria”
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison
Contributing partner:
Ludwig-Maximilian-Universität München (LMU)
Scientific article available at:
“Virology”
Accessibility of covariance information creates vulnerability in Federated Learning frameworks
Contributing partner:
Institute of Computational Biology, Helmholtz Munich; Life and Medical Sciences Institute, University of Bonn
Scientific article available at:
“Bioinformatics”
Risk Factors for Community and Intrahousehold Transmission of SARS-CoV-2: Modeling in a Nationwide French Population-Based Cohort Study, the EpiCoV Study
Contributing partner:
INSERM, Paris
Scientific article available at:
“American Journal of Epidemiology”
Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project
Contributing partner:
ISGlobal, Barcelona
Scientific article available at:
“Vaccines”
Incidence and Determinants of Symptomatic and Asymptomatic SARS-CoV-2 Breakthrough Infections After Booster Dose in a Large European Multicentric Cohort of Health Workers-ORCHESTRA Project
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Journal of Epidemiology and Global Health”
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“eClinicalMedicine”
Video abstract available here
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers
Contributing partner:
Ludwig-Maximilian-Universität München (LMU)
Scientific article available at:
“Viruses”
How European Research Projects Can Support Vaccination Strategies: The Case of the ORCHESTRA Project for SARS-CoV-2
Contributing partner:
University of Verona, University of Munich (LMU)
Scientific article available at:
“Vaccines”
SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020–31 January 2023
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Viruses”
Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection
Contributing partner:
Fondazione Penta ONLUS (PENTA)
Scientific article available at:
“Pediatrics”
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
Contributing partner:
Ludwig-Maximilian-Universität München (LMU)
Scientific article available at:
“BMC Infectious Diseases”
Factors Associated with SARS-CoV-2 Infection before Vaccination among European Health Care Workers
Contributing partner:
University of Torino
Scientific article available at:
“La Medicina del Lavoro”
Comparison of Depression and Anxiety Following Self-reported COVID-19–Like Symptoms vs SARS-CoV-2 Seropositivity in France
Contributing partner:
INSERM, Paris
Scientific article available at:
“JAMA Netw Open”
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in Solid Organ Transplant Recipients.The multicentre ORCHESTRA cohort
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“Clinical Microbiology and Infection”
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Contributing partner:
French National Institute of Health and Medical Research (INSERM)
Scientific article available at:
“Genome Medicine”
The Effect of the Immunization Schedule and Antibody Levels (Anti-S) on the Risk of SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers in Northern Italy
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“Vaccines”
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Infectious Diseases and Therapy”
Integrative modelling of reported case numbers and seroprevalence reveals time-dependent test efficiency and infectious contacts
Contributing partner:
Ludwig-Maximilian-Universität München (LMU)
and Helmholtz Zentrum München (HMGU)
Scientific article available at:
“Epidemics”
Impact of Omicron variant infection on assessment of spike-specific Immune responses using Quan-T-Cell SARS-CoV-2 assay and Roche Elecsys anti-SARS-CoV-2-S
Contributing partner:
Ludwig-Maximilian – Universität München (LMU)
Scientific article available at:
“Pathology and Molecular Diagnostics”
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients
Contributing partner:
University of Bologna
Scientific article available at:
“Microorganisms”
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
Contributing partner:
University of Antwerp (UAntwerp)
University of Verona (UNIVR)
Scientific article available at:
“JCI The Journal of Clinical Investigation”
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“Clinical Infectious Diseases”
SARS-CoV-2 Breakthrough Infections in Health Care Workers: An Italian Retrospective Cohort Study on Characteristics, Clinical Course and Outcomes
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“J. Clin. Med.”
Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: An individual-level analysis within 13 months in the ORCHESTRA cohort
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“Frontiers in Immunology”
Use of health care services among people with Covid-19 symptoms in the first pandemic peak in France
Contributing partner:
INSERM, Paris
Scientific article available at:
“Plos One”
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors
Contributing partner:
Universiteit Antwerpen (UANTWERPEN)
Scientific article available at:
“Frontiers in Immunology”
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections
Contributing partner:
University Hospital LMU Munich
Scientific article available at:
“Frontiers in Immunology”
Effectiveness of prevention of SARS-CoV-2 transmission among unvaccinated Italian healthcare workers
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“Med Lav”
Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021–31 May 2022
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Viruses”
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron Variant of Concern
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
eLife (elifesciences.org)
SARS-CoV-2 and Its Variants in Thrice-Infected Health Workers: A Case Series from an Italian University Hospital
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Viruses
Global Association of COVID-19 Pandemic Measures with Cancer Treatment: A Systematic Review and Meta-Analysis
Contributing partner:
University of Bologna
Scientific article available at:
“Cancers”
Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021–22: a status-based multi-variant model
Contributing partner:
French National Institute of Health and Medical Research (INSERM)
Scientific article available at:
“BMC Infectious Diseases”
The COVID HOME study research protocol: Prospective cohort study of non-hospitalised COVID-19 patients
Contributing partner:
University Medical Center Groningen (UMCG)
Scientific article available at:
“PLOS ONE”
European HPC cloud infrastructure for managing SARS-CoV-2 data in compliance with GDPR
Contributing partner:
CINECA Consorzio Interuniversitario
Scientific article available at:
“European Journal of Public Health”
Determinants of Anti-S Immune Response at 9 Months after COVID-19 Vaccination in a Multicentric European Cohort of Healthcare Workers—ORCHESTRA Project
Contributing partner:
University of Bologna
Scientific article available at:
“Viruses”
Labor market participation and depression during the COVID-19 pandemic among young adults (18 to 30 years): A nationally representative study in France
Contributing partner:
INSERM, Paris
Scientific article available at:
“Frontiers in Public Health”
Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Hematological Oncology”
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
Contributing partner:
INSERM, Paris
Scientific article available at:
“Clinical Microbiology and Infection”
Association of Patients’ Epidemiological Characteristics and Comorbidities
with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of
an Umbrella Systematic Review and Meta-Analysis
Contributing partner:
Servicio Andaluz de Salud (SAS)
Scientific article available at:
“Biomedicines”
Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers – ORCHESTRA project
Contributing partner:
University of Bologna, University of Verona
Scientific article available at:
“Frontiers in Immunology”
Perceived Psychological Impact on Children and Parents of Experiencing COVID-19 Infection in One or More Family Members
Contributing partner:
Fondazione Penta ONLUS (PENTA)
Scientific article available at:
“Children”
Usefulness and Limitations of Anti-S IgG Assay in Detecting Previous SARS-Cov-2 Breakthrough Infection in Fully Vaccinated Healthcare Workers
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Diagnostics”
Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study
Contributing partner:
University of Bologna (UNIBO)
Helmholtz Zentrum München (HMGU)
University of Antwerp (UAntwerp)
Scientific article available at:
“Biomedicines”
Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response
Contributing partner:
University of Verona (UNIVR)
University Medical Center Groningen (UMCG)
Scientific article available at:
“The Lancet Regional Health – Europe”
SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers
Contributing partner:
University of Bologna (UNIBO)
University of Verona (UNIVR)
Scientific article available at:
“Vaccines”
Exhaustion in Healthcare Workers after the First Three Waves of the COVID-19 Pandemic
Contributing partner:
National Institute of Public Health (INSP)
Scientific article available at:
“International Journal of Environmental Research and Public Health”
When Lack of Trust in the Government and in Scientists Reinforces Social Inequalities in Vaccination Against COVID-19
Contributing partner:
INSERM, Paris
Scientific article available at:
“Frontiers in Public Health”
Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
Contributing partner:
The Congolese Foundation for Medical Research (FCRM)
Scientific article available at:
“BMC Infectious Diseases”
Preliminary Evidence on Pulmonary Function after Asymptomatic and Mild COVID-19 in Children
Contributing partner:
Fondazione Penta ONLUS (PENTA)
Scientific article available at:
“Children”
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“European Journal of Clinical Microbiology & Infectious Diseases”
Harmonization and standardization of data for a pan-European cohort on SARS- CoV-2 pandemic
Contributing partner:
Berlin Institute of Health (BIH/Charité)
Scientific article available at:
“npj Digital Medicine”
Social Isolation Among Older Adults in the Time of COVID-19: A Gender Perspective
Contributing partner:
French national institute of health and medical research (INSERM)
Scientific article available at:
“Frontiers in Public Health”
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV
Contributing partner:
French National Institute of Health and Medical Research (INSERM)
Scientific article available at:
“PLOS ONE”
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“Microorganisms”
Higher risk, higher protection: COVID-19 risk among immigrants in France—results from the population-based EpiCov survey
Contributing partner:
INSERM, Paris
Scientific article available at:
“European Journal of Public Health”
Serological response after SARS-CoV2 vaccination in healthcare workers: a multicenter study
Contributing partner:
University of Bologna (UNIBO)
Scientific article available at:
“La Medicina del Lavoro, Journal of the Italian Society of Occupational Health”
Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis
Contributing partner:
University of Bologna (UNIBO)
University of Verona (UNIVR)
Servicio Andaluz de Salud (SAS)
Scientific article available at:
“Clinical Microbiology and Infection”
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Annals of Oncology”
Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease
Contributing partner:
Fondazione Penta ONLUS (PENTA)
Scientific article available at:
“Frontiers in Pediatrics”
Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study
Contributing partner:
University of Verona (UNIVR)
Scientific article available at:
“Journal of Infection”
Spatially resolved qualified sewage spot sampling to track SARS-CoV-2 dynamics in Munich – One year of experience
Contributing partner:
Ludwig-Maximilian- Universität München (LMU)
Scientific article available at:
“Science of The Total Environment”
Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities
Contributing partner:
Ludwig-Maximilian – Universität München (LMU)
and Helmholtz Zentrum München (HMGU)
Scientific article available at:
“The Lancet Global Health”
ORCHESTRA project in Romania – a prospective occupational cohort to study the impact of COVID-19 pandemic on healthcare workers
Contributing partner:
National Institute of Public Health (INSP)
Scientific article available at:
“Romanian Journal of Occupational Medicine”
SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know
Contributing partner:
UNIBO, Italy
Scientific article available at:
“Transplant International”
From first to second wave: follow-up of the prospective Covid-19 cohort (KoCo19) in Munich (Germany)
Contributing partner:
Ludwig-Maximilian- Universität München (LMU)
Scientific article available at:
“BMC infectious diseases”
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers
Contributing partner:
Fondazione Penta ONLUS (PENTA)
Scientific article available at:
“PEDIATRICS®”
SARS-CoV-2 vaccination in solid-organ transplant recipients: What the clinician needs to know
Contributing partner:
University of Bologna
Scientific article available at:
“Transplant International”
A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay
Contributing partner:
Ludwig-Maximilian – Universität München (LMU)
Scientific article available at:
“eBioMedicine”
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay
Contributing partner:
Ludwig-Maximilian- Universität München (LMU)
Scientific article available at:
“Frontiers in Immunology”
Left ventricle longitudinal strain alterations in asymptomatic or mildly symptomatic pediatric patients with recent SARS-CoV-2 infection
Contributing partner:
Fondazione Penta ONLUS (PENTA)
Scientific article available at:
“European Heart Journal – Cardiovascular Imaging”
The following overview shows all deliverables. Approved and public deliverables can be
downloaded.
| Del Rel. No | Title | Lead Beneficiary | Dissemination level and availability |
|
D1.1 |
Project Management Guidelines |
UNIVR |
Download |
|
D1.2 |
Revised project plan following kick off meeting |
UNIVR |
Confidential, approved |
|
D1.3 |
Database for Ethics Approval |
UNIVR |
Confidential, approved |
|
D1.4 |
Portfolio presentations of final Conference |
UNIVR |
Public, in progress |
|
D1.5 |
Interim activity report |
UNIVR |
Confidential, approved |
|
D1.6 |
Ethics Board Report Interim |
UNIVR |
Confidential, approved |
|
D1.7 |
Ethics Board Report Final |
UNIVR |
Confidential, in progress |
|
D2.1 |
Systematic review of the literature on determinants of |
SAS |
Download |
|
D2.2 |
Algorithms for supporting clinical decision-making for |
INSERM |
Public, in progress |
|
D2.3 |
Algorithms for guiding therapeutic decisions for |
UHC |
|
|
D2.4 |
Algorithms for management of long term sequelae of |
UNIVR |
Public, in progress |
|
D2.5 |
Final report of 6-month follow up by clinical, |
UNIVR |
Download |
|
D2.6 |
Final report of 12-month follow up by clinical, |
UNIVR |
|
|
D2.7 |
Assessment of clinical and epidemiological |
UNIVR |
Public, in progress |
|
D3.1 |
Guiding principles report on type and source of |
INSERM |
Confidential, approved |
|
D3.2 |
Preliminary report on seroprevalence in EU countries |
INSERM |
Download |
|
D3.3 |
Report on genotypic and epigenetic features related to |
HMGU |
Public, in progress |
|
D3.4 |
Report on consequences of lockdown and other prevention |
LIH |
Public, in progress |
|
D3.5 |
Report on the serological immune responses of |
LMU MUENCHEN |
|
|
D3.6 |
Identification of break-through infections in |
LMU MUENCHEN |
|
|
D4.1 |
Report on ORCHESTRA-fragile population |
UNIBO |
Confidential, approved |
|
D4.2 |
Protocol for prospective cohort of vaccinated and non |
UNIBO |
Confidential, approved |
|
D4.3 |
Quality and kinetic of early immune response to COVID-19 |
UNIBO |
Download |
|
D4.4 |
Quality and kinetic of long-term immune response to |
UNIBO |
|
|
D4.5 |
Clinical algorithms for diagnostic and therapeutic |
SAS |
Public, in progress |
|
D4.6 |
Clinical algorithms for long-term management of COVID-19 |
UNIVR |
Public, in progress |
|
D4.7 |
Report of consequences of lockdown and preventive |
UNIBO |
Public, in progress |
|
D4.8 |
Quality and kinetic of long-term immune response to |
UNIBO |
Public, in progress |
|
D4.9 |
Burden and management of persisting COVID-19 in severe |
UNIBO |
Public, in progress |
|
D5.1 |
Datasets of clinical and microbiological data of the |
UNIBO |
Confidential, in progress |
|
D5.2 |
Results of analysis of determinants of COVID-19 and |
UNIBO |
|
|
D5.3 |
Report on feasibility of enrolling vaccinated HCWs in |
UNIBO |
|
|
D5.4 |
Guidance for prevention of SARS-CoV-2 infection in |
UNIOVI |
Public, in progress |
|
D5.5 |
Interim analysis of serology results after |
UNIBO |
Download |
|
D5.6 |
Immunological response in vaccinated and not vaccinated |
UNIBO |
Download |
|
D5.7 |
First interim risk analysis of breakthrough |
LMU MUENCHEN |
Download |
|
D5.8 |
Incidence of breakthrough infections |
LMU MUENCHEN |
Download |
|
D5.9 |
Final risk analysis of breakthrough infection |
LMU MUENCHEN |
|
|
D5.10 |
Final analysis of serology results after vaccination |
UNIBO |
Download |
|
D5.11 |
Risk analysis of breakthrough infection in healthcare |
UNIVR |
Public, in progress |
|
D5.12 |
Analysis of serology results after vaccination in |
UNIBO |
Public, in progress |
|
D5.13 |
Analysis of post-COVID-19 syndrome in HCW (final |
UNIOVI |
Public, in progress |
|
D6.1 |
Standardised protocol and manual on collection and |
UANTWERPEN |
Confidential, approved |
|
D6.2 |
Dataset of human genome sequencing of patients with |
UNIBO |
Download |
|
D6.3 |
Report on viral loads, viral genome sequences of |
INSERM |
Download |
|
D6.4 |
Report on serology analysis of retrospective COVID-19 |
INSERM |
Download |
|
D6.5 |
Report on cytokine chemokine analysis in COVID-19 |
UANTWERPEN |
Download |
|
D6.6 |
First report on serology in fragile populations |
INSERM |
Download |
|
D6.7 |
First report on immunity analysis from prospective |
UANTWERPEN |
Download |
|
D6.8 |
Report on viral loads, viral genome sequences on |
INSERM |
Download |
|
D6.9 |
Final report on cellular immunity analysis for |
UANTWERPEN |
Public, in progress |
|
D6.10 |
Dataset of 16S rRNA sequencing of retrospective |
UNIBO |
Download |
|
D6.11 |
Dataset of human genomic sequencing outcome of patients |
UNIBO |
|
|
D6.12 |
Report on dataset of genome-wide methylation |
HMGU |
|
|
D6.13 |
Report on serology analysis including long-term sequelae |
UANTWERPEN |
|
|
D6.14 |
Report on cytokine chemokine analysis in COVID-19 |
UANTWERPEN |
|
|
D6.15 |
Final report on dataset of human genetic variants |
UNIBO |
Public, in progress |
|
D6.16 |
Report on respiratory and gut microbiome (dynamics for |
UANTWERPEN |
Public, in progress |
|
D6.17 |
Report on functional validation of human genetic |
UNIBO |
Public, in progress |
|
D6.18 |
Report on viral genome sequences and serology in case of |
UANTWERPEN |
|
|
D6.19 |
Report on cellular immunity analysis for prospective |
UANTWERPEN |
Public, in progress |
|
D6.20 |
Report on viral genome sequences and serology in |
UANTWERPEN |
Public, in progress |
|
D7.1 |
Data Management Plan |
CINES |
Confidential, approved |
|
D7.2 |
Report on harmonisation of data collection and |
Charité |
Confidential, approved |
|
D7.3 |
First version of report on Data Protection and Access |
Charité |
Confidential, approved |
|
D7.4 |
Report on feasibility assessment of statistical analysis |
CINES |
Confidential, approved |
|
D7.5 |
Report on NHs |
USTUTT |
Confidential, approved |
|
D7.6 |
First report on ORCHESTRA portal: a preliminary |
CINECA |
Confidential, approved |
|
D7.7 |
Second version of report on Data Protection and Access |
Charité |
Confidential, approved |
|
D7.8 |
Update on data management plan |
CINES |
Confidential, approved |
|
D8.1 |
Report on estimates of intervention effects using |
HMGU |
Download |
|
D8.2 |
Report on estimates of intervention effects using |
HMGU |
|
|
D8.3 |
Report on risk associated with socio-economic |
ISGLOBAL |
|
|
D8.4 |
Report on impact of pandemic on socio-economic |
ISGLOBAL |
|
|
D8.5 |
Report on impact of delayed service on fragile |
ISGLOBAL |
Public, in progress |
|
D8.6 |
Report on assessment of intra-host viral dynamics and |
INSERM |
|
|
D8.7 |
In silico model of vaccination strategies |
HMGU |
Download |
|
D8.8 |
Final report on translation of strategies to LMICs |
ISGLOBAL |
Public, in progress |
|
D8.9 |
Report on the impact of the pandemic on healthcare |
ISGLOBAL |
Public, in progress |
|
D9.1 |
Working plan |
UMCG |
Confidential, approved |
|
D9.2 |
Protocol Evaluation Framework |
UMCG |
Confidential, approved |
|
D9.3 |
Consortium agreement with new Cohorts |
UMCG |
Confidential, approved |
|
D9.4 |
Final document with scientific highlights |
UNIVR |
Public, in progress |
|
D10.1 |
Communication and dissemination strategy plan and |
UHC |
Download |
|
D10.2 |
Social media accounts created and accredited |
UHC |
Download |
|
D10.3 |
First regular graphics visualized |
UHC |
Download |
|
D10.4 |
Anonymous dataset for the public published |
UHC |
Download |
|
D10.5 |
Call for first science challenge based on anonymized |
UHC |
Download |
|
D10.6 |
Cohort Builder and Dashboard online |
UHC |
Download |
|
D10.7 |
Automated emails service for stakeholders |
UHC |
Download |
|
D11.1 |
H – Requirement No. 1 |
UNIVR |
Confidential, approved |
|
D11.2 |
H – Requirement No. 2 |
UNIVR |
Confidential, in progress |
|
D11.3 |
HCT – Requirement No. 3 |
UNIVR |
Confidential, approved |
|
D11.4 |
HCT – Requirement No. 4 |
UNIVR |
Confidential, approved |
|
D11.5 |
POPD – Requirement No. 6 |
UNIVR |
Confidential, approved |
|
D11.6 |
NEC – Requirement No. 7 |
UNIVR |
Confidential, approved |
Acknowledgements
ORCHESTRA has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101016167. [Long version]
***
Supported by the H2020-RIA GA No 101016167. [Short version]
***
All publications of research results or information from EU-funded projects must be clearly marked with the EU-emblem (EU-flag) and information about the financial funding mechanism.
You need to acknowledge the EU-funding when:
writing articles in newspapers, journals
being interviewed e.g. for a newspaper, journal, radio, tv programme
producing printed material such as brochures/leaflets/posters
having presentations in public fora, e.g. conferences, seminars
For more information, please consult the ORCHESTRA Publication Policy, available upon request: pmu@orchestra-cohort.eu
Disclaimer clause
The views expressed in this [publication/document/paper…] are the sole responsibility of the author and the Commission is not responsible for any use that may be made of the information it contains.